← Open Payments lookup

MATTHEW BOGOYAS: Open Payments

NPI 1336508423 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$202,282 in 277 payments from 11 companies in 2025. Trend: 2023 $81,493 · 2024 $185,707 · 2025 $202,282

Speaker / faculty: $144,556Honoraria: $29,200Consulting: $13,688Travel & lodging: $8,930Food & beverage: $5,691Education: $216
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.86$72,264
Teva Pharmaceuticals USA, Inc.48$39,393
Neurocrine BioSciences, Inc.40$37,352
Axsome Therapeutics, Inc.41$32,440
Otsuka America Pharmaceutical, Inc.48$17,907
Janssen Scientific Affairs, LLC1$2,725
Janssen Pharmaceuticals, Inc7$83
Alkermes, Inc.3$64
Otsuka Pharmaceutical Development & Commercialization, Inc.1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: COBENFY, INGREZZA, Auvelity, UZEDY, ABILIFY MAINTENA, AUSTEDO XR, SPRAVATO, REXULTI.

Industry payments across WA — which companies pay providers there.